Cardiovascular mortality trends in the United States, 1999–2024: an interrupted time-series analysis

U.S. cardiovascular mortality rose during the COVID-19 pandemic. Whether the increase represented a lasting departure from the long-term decline remains uncertain. We analyzed annual U.S. age-adjusted mortality rates for circulatory diseases (ICD-10 I00–I99) from CDC WONDER, 1999–2024. We described observed trends and calculated year-specific differences between 2020 and 2024 rates and forecasts fitted through 2019. Interrupted time-series ARIMA models estimated model-specific intervention terms. We assessed alternative trends and intervention responses, pre-pandemic forecast performance, multiple-cause-of-death data, and sex-specific patterns. The national age-adjusted cardiovascular mortality rate rose from 214.6 deaths per 100,000 in 2019 to 233.3 in 2021, then declined to 212.9 in 2024. Observed rates exceeded the upper nominal 95% prediction limit of the 1999–2019 ARIMA forecast in 2020 and 2021. In 2024, the observed rate was 5.0 per 100,000 above that forecast but within its prediction interval; it was 1.4 below a damped-trend forecast fitted to 2010–2019. Pre-pandemic backtesting showed weak interval calibration for several forecasting models. The selected intervention model estimated a post-2020 Step coefficient of 28.12 per 100,000 (95% CI, 21.19–35.06), a model-specific parameter distinct from the annual forecast differences. A recovering response fit nearly as well as a permanent response in a separate model comparison. U.S. cardiovascular mortality increased in 2020–2021 and declined through 2024. The early increase exceeded the reference forecast’s nominal prediction limits, but estimates of later departures depended on the forecasting model. The available annual data cannot distinguish a permanent shift from gradual recovery.

Authors

Institutions

Publication Details

Journal
BMC Cardiovascular Disorders
Published
2026-11-13
DOI
https://doi.org/10.1186/s12872-026-07031-w
Primary Topic
Healthcare Systems and Public Health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Cardiovascular mortality trends in the United States, 1999–2024: an interrupted time-series analysis

Mazhar Ali, Martha Gulati, Ali Rohan, Andrew Michael Goldsweig et al.
3 links
BMC Cardiovascular Disorders
Healthcare Systems and Public Health
article

Cardiovascular mortality trends in the United States, 1999–2024: an interrupted time-series analysis

Mazhar Ali, Martha Gulati, Ali Rohan, Andrew Michael Goldsweig, Gregg C. Fonarow, Aliya Noor, Iqra Moatter Nurie, Muhammad Ahmad, Ravi Kumar Pandey
article en

Abstract

U.S. cardiovascular mortality rose during the COVID-19 pandemic. Whether the increase represented a lasting departure from the long-term decline remains uncertain. We analyzed annual U.S. age-adjusted mortality rates for circulatory diseases (ICD-10 I00–I99) from CDC WONDER, 1999–2024. We described observed trends and calculated year-specific differences between 2020 and 2024 rates and forecasts fitted through 2019. Interrupted time-series ARIMA models estimated model-specific intervention terms. We assessed alternative trends and intervention responses, pre-pandemic forecast performance, multiple-cause-of-death data, and sex-specific patterns. The national age-adjusted cardiovascular mortality rate rose from 214.6 deaths per 100,000 in 2019 to 233.3 in 2021, then declined to 212.9 in 2024. Observed rates exceeded the upper nominal 95% prediction limit of the 1999–2019 ARIMA forecast in 2020 and 2021. In 2024, the observed rate was 5.0 per 100,000 above that forecast but within its prediction interval; it was 1.4 below a damped-trend forecast fitted to 2010–2019. Pre-pandemic backtesting showed weak interval calibration for several forecasting models. The selected intervention model estimated a post-2020 Step coefficient of 28.12 per 100,000 (95% CI, 21.19–35.06), a model-specific parameter distinct from the annual forecast differences. A recovering response fit nearly as well as a permanent response in a separate model comparison. U.S. cardiovascular mortality increased in 2020–2021 and declined through 2024. The early increase exceeded the reference forecast’s nominal prediction limits, but estimates of later departures depended on the forecasting model. The available annual data cannot distinguish a permanent shift from gradual recovery.

BMC Cardiovascular Disorders
Houston Methodist (US), Baystate Medical Center (US), King Edward Medical University (PK), University of Lahore (PK), Khyber Medical College (PK), Baqai Medical University (PK), UCLA Health (US), Baystate Health (US), Sharif Medical and Dental College (PK)
Good health and well-being
Healthcare Systems and Public Health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon